Case report: adverse drug reaction due to ciprofloxacin - a case of fixed drug eruption
DOI:
https://doi.org/10.47957/ijpda.v13i1.613Keywords:
Ciprofloxacin, fixed drug eruption, ADR, erythromatousAbstract
A 45-year-old female presented to the dermatology department with complaints of uterine itching and a burning sensation during micturition. Ciprofloxacin 500mg PO BD was prescribed to alleviate the symptoms. However, within two hours of initiating treatment, the patient developed red lesions on her right forearm and left hand, associated with fluid-filled lesions on an erythematous base. Ciprofloxacin was identified as the causative agent of this adverse drug reaction (ADR). Given the potential severity of ADRs associated with Ciprofloxacin, it is crucial to closely monitor patients for early signs of reactions. Early recognition, prompt dechallenge, and effective management strategies are necessary to ensure patient safety.
Downloads
References
Naga subrahmanyam S, TagooreVijaya Lakshmi, Pradeep Kumar Reddy. Case Report on Drug Induced Erythroderma. Inventi Rapid: Pharmacy Practice,2020(4):1-3,2020.
Dr.k. lakshmisurekha, Dr. Naga Subrahmanyam S and Dr.P. Pavankumar.2020, Carbamazepine Induced Cutaneous Reactions. Int J Recent Sci Res. 11(01), pp. 36871-36873. DOI: http://dx.doi.org/10.24327/ijrsr.2020.1101.5014
S.nagasubrahmanyam et.al., carbamazepine induced drug rash with eosinophilia and systemic symptoms, journal of drug delivery and therapeutics, vol 9 no 1- s(2019):367-368. DOI: http://dx.doi.org/10.22270/jddt.v9i1-s.2330
S.nagasubrahmanyam et.al.,cefotaxime induced macular rashes, Saudi journal of medical and pharmaceuticalsciences,vol-4,iss-9(sept,2018):1032-1034. doi:10.21276/sjmps.2018.4.9.7
Naga Subrahmanyam S, Vijaya Lakshmi DT, Naga Raju GV, Pavan Kumar GV, Gayathri G, Carbamazepine Induced Drug Rash with Eosinophilia and Systemic Symptoms, Journal of Drug Delivery and Therapeutics. 2019; 9(1-s):367-368 DOI: http://dx.doi.org/10.22270/jddt.v9i1-s.2330
Naga Subrahmanyam S et al., Int. J. Res. Pharm. Sci., 11(1), 173-175
Ciprofloxacin. [Dec;2016 ];http://livertox.nih.gov/Ciprofloxacin.htm National Institutes of Health. 2016 09-6 [Google Scholar].
Ciprofloxacin exposure leading to fatal hepatotoxicity: An unusual correlation. Unger C, Al-Jashaami LS. Am J Case Rep. 2016;17:676–681. [PMC free article] [PubMed] [Google Scholar].
Teraki, Y.; Shiohara, T. IFN-?–producing effector CD8+ T cells and IL-10–producing regulatory CD4+ T cells in fixed drug eruption. J. Allergy Clin. Immunol. 2003, 112, 609–615. [CrossRef].
Jolly, H.W.; Sherman, I.J.; Carpenter, C.L.; Nesbitt, L.T.; Meek, T.J. Fixed Drug Eruptions to Tetracyclines. Arch. Dermatol. 1978, 114, 1484–1485. [CrossRef].
Ben Fadhel, N.; Chaabane, A.; Ammar, H.; Ben Romdhane, H.; Soua, Y.; Chadli, Z.; Zili, J.; Boughattas, N.A.; Ben Fredj, N.; Aouam, K.; et al. Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption. Contact Dermat. 2019, 81, 336–340. [CrossRef].
Flowers, R.; Brodell, R.; Brents, M.; Wyatt, J.P. Fixed Drug Eruptions: Presentation, Diagnosis, and Management. South. Med. J. 2014, 107, 724–727. [CrossRef].
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
